An Open Label, Multi-Center, Non-Interventional Post-Marketing Surveillance to Monitor the Safety and Efficacy of ALTARGO® (Retapamulin) Administered in Korean Patients According to the Prescribing Information.
Woosung HongYil-Seob LeeChun-Wook ParkMoon-Soo YoonYoung Suck RoPublished in: Annals of dermatology (2018)
Topical retapamulin is to be well-tolerated and effective in patients with bacterial skin infections of locally approved prescribing information.